ABILIFY

Date	18 February 2009
Pharmaceutical formulation	ABILIFY 5 mg tablets, pack of 28 (CIP: 364 069-7) ABILIFY 10 mg tablets, pack of 28 (CIP: 364 073-4) and pack of 98 (CIP: 565 796-3) ABILIFY 15 mg tablets, pack of 28 (CIP: 364 078-6) and pack of 98 (CIP: 565 798-6) ABILIFY 10 mg orodispersible tablets, pack of 28 (CIP: 369 214-5) ABILIFY 15 mg orodispersible tablets, pack of 28 (CIP: 369 217-4)
ATC code	N05AX12
Active ingredient	aripiprazole
Laboratory / Manufacturer	BRISTOL-MYERS SQUIBB
Reason for request	Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication "for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of new manic episodes in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment". Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals: Pack of 28. Inclusion on the List of Medicinal Products Approved for Use by Hospitals: Pack of 98.

Documents